NEW YORK (GenomeWeb) – MDxHealth announced today that it has signed a commercial service agreement with the Fondazione Luigi Maria Monti - Istituto Dermopatico dell' Immacolata (IDI) research Hospital in Rome to provide its SelectMDx prostate cancer test as a service.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.